Cargando…

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer

BACKGROUND: The CXC chemokine, CXCL12, and its receptor, CXCR4 promote metastases of a variety of solid tumors, including non-small cell lung cancer (NSCLC). The expression of CXCR4 on tumor cells may represent a critical biomarker for their propensity to metastasize. This study was performed to eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reckamp, Karen L, Figlin, Robert A, Burdick, Marie D, Dubinett, Steven M, Elashoff, Robert M, Strieter, Robert M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708193/ https://www.ncbi.nlm.nih.gov/pubmed/19563666 http://dx.doi.org/10.1186/1471-2407-9-213

Ejemplares similares

Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis
por: Pan, Judong, et al.
Publicado: (2006)

Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells
por: Riedl, Karen, et al.
Publicado: (2003)

Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5
por: Cripps, James G., et al.
Publicado: (2012)

Circulating cytokeratin-positive cells and tumor budding in colorectal cancer
por: Märkl, Bruno, et al.
Publicado: (2016)

CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection
por: Londhe, Vedang A, et al.
Publicado: (2005)

Dose-dependent Effect of Statin Therapy on Circulating CXCL12 Levels in Patients with Hyperlipidemia
por: Camnitz, Will, et al.
Publicado: (2012)

Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Correction: Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
por: Srivastava, Minu K., et al.
Publicado: (2012)

Identifying squamous cell carcinoma and cytokeratin-derived amyloid with pan-cytokeratin AE1/AE3 during Mohs micrographic surgery
por: Sidey, Kirk, et al.
Publicado: (2020)

Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis
por: Addison, Christina L, et al.
Publicado: (2004)

Pan-Cytokeratin Positive Fibroblastic Osteosarcoma of Jaw: An Extremely Rare Entity in a Pediatric Patient
por: Urs, Aadithya B, et al.
Publicado: (2019)

Myeloid Clusters Are Associated with a Pro-Metastatic Environment and Poor Prognosis in Smoking-Related Early Stage Non-Small Cell Lung Cancer
por: Zhang, Wang, et al.
Publicado: (2013)

SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10
por: Sharma, Sherven, et al.
Publicado: (2003)

Detection of Circulating Tumor Cells in Hepatocellular Carcinoma Using Antibodies against Asialoglycoprotein Receptor, Carbamoyl Phosphate Synthetase 1 and Pan-Cytokeratin
por: Li, Jun, et al.
Publicado: (2014)

Verification of HE-based CTV in laryngeal and hypopharyngeal cancer using pan-cytokeratin
por: Ligtenberg, Hans, et al.
Publicado: (2018)

The Role of Fibrocytes in Sickle Cell Lung Disease
por: Field, Joshua J., et al.
Publicado: (2012)

Allantodapsone is a Pan-Inhibitor of Staphylococcus aureus Adhesion to Fibrinogen, Loricrin, and Cytokeratin 10
por: Prencipe, Filippo, et al.
Publicado: (2022)

Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma
por: Zhang, Qian, et al.
Publicado: (2021)

Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood
por: Mikolajczyk, Stephen D., et al.
Publicado: (2011)

Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer
por: Srivastava, Minu K, et al.
Publicado: (2012)

Cytokeratin-negative small cell lung carcinoma
por: Terada, Tadashi
Publicado: (2011)

Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal
por: Gradilone, Angela, et al.
Publicado: (2011)

Cytokeratin 20-positive hepatocellular carcinoma
por: Fanni, D., et al.
Publicado: (2009)

Cytokeratin-positive cells in bone marrow for identifying distant micrometastasis of gastric cancer.
por: Maehara, Y., et al.
Publicado: (1996)

Stem Cell Markers (Cytokeratin 17 and Cytokeratin 19) in Scarring and Nonscarring Alopecia
por: El Sakka, Dalia, et al.
Publicado: (2016)

Cytokeratin‐positive follicular dendritic cell sarcoma: A mimic of carcinoma
por: Ricks, Elizabeth, et al.
Publicado: (2021)

Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer
por: Hinz, Sebastian, et al.
Publicado: (2015)

A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients
por: Rossi, Elisabetta, et al.
Publicado: (2021)

Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non‐muscle‐invasive bladder cancer
por: Muilwijk, Tim, et al.
Publicado: (2021)

Cytokeratin 7-positive/cytokeratin 20-negative cecal adenocarcinoma metastatic to the uterine cervix: a case report
por: Toyoshima, Masafumi, et al.
Publicado: (2016)

Cytokeratins 8 and 19 in the Mouse Placental Development
por: Tamai, Yoshitaka, et al.
Publicado: (2000)

Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients
por: Nanou, Afroditi, et al.
Publicado: (2018)

Cytokeratin-Positive Osteosarcoma Simulating Sarcomatoid Metastatic Carcinoma
por: Murtaza, Hamza, et al.
Publicado: (2020)

Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer
por: Märkl, Bruno, et al.
Publicado: (2019)

CCL19 reduces tumour burden in a model of advanced lung cancer
por: Hillinger, S, et al.
Publicado: (2006)

Circulating CXCR3(+) Tfh cells positively correlate with neutralizing antibody responses in HCV-infected patients
por: Zhang, Jian, et al.
Publicado: (2019)

Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse
por: Saloustros, Emmanouil, et al.
Publicado: (2011)

Cytokeratin positivity in myxopapillary ependymoma – a potential diagnostic pitfall
por: Hussein, Sundus A, et al.
Publicado: (2008)

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
por: Zhuo, Jianyong, et al.
Publicado: (2021)

Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR
por: Park, Hyung Seok, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6n3mpmb56dumdoqi3sgf0b3c59